Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its...

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies...

Can Psilocybin Assisted Psychotherapy Change Attachment Style?

PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and...

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment...

Octarine Bio announces closing of extended seed round financing of $1.2...

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using...

NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for...

DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a...

Load more